Arkolith/Insider Trading/FREQ/Form 4

Lucchino David L.

President and CEO, DirectorFrequency Therapeutics, Inc. (FREQ) · full profile →Form 4 · filed Jul 11, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2K
Net Open-Market Flow
-$2K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 10, 2023Sell(S)3K$0.38$985443K
Jul 10, 2023Option exercise(M)9K——452K
Jul 7, 2023Option exercise(M)9K——445K
Jul 7, 2023Sell(S)3K$0.35$922436K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 10, 2023Option exercise(M)9K——264K
Jul 7, 2023Option exercise(M)9K——273K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001127602-23-020571) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML